Afya (NASDAQ:AFYA) Now Covered by Analysts at UBS Group

UBS Group began coverage on shares of Afya (NASDAQ:AFYAGet Free Report) in a research report issued to clients and investors on Friday, Briefing.com reports. The firm set a “neutral” rating and a $19.50 price target on the stock. UBS Group’s target price points to a potential upside of 12.72% from the stock’s current price.

Separately, Morgan Stanley reduced their target price on Afya from $21.00 to $19.00 and set an “equal weight” rating for the company in a report on Friday, June 21st. Four research analysts have rated the stock with a hold rating, According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $21.13.

Get Our Latest Report on Afya

Afya Price Performance

NASDAQ AFYA opened at $17.30 on Friday. Afya has a fifty-two week low of $14.57 and a fifty-two week high of $22.48. The stock’s 50-day moving average is $17.64 and its two-hundred day moving average is $18.22. The firm has a market cap of $1.62 billion, a P/E ratio of 16.17, a price-to-earnings-growth ratio of 0.46 and a beta of 0.97. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.28 and a quick ratio of 1.28.

Institutional Investors Weigh In On Afya

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Doma Perpetual Capital Management LLC acquired a new position in Afya during the 4th quarter valued at $6,467,000. Marshall Wace LLP increased its holdings in shares of Afya by 41.8% during the 2nd quarter. Marshall Wace LLP now owns 336,985 shares of the company’s stock worth $5,948,000 after purchasing an additional 99,416 shares during the period. Millennium Management LLC raised its position in shares of Afya by 45.0% during the second quarter. Millennium Management LLC now owns 291,164 shares of the company’s stock valued at $5,139,000 after buying an additional 90,383 shares during the last quarter. Renaissance Technologies LLC lifted its stake in shares of Afya by 19.7% in the second quarter. Renaissance Technologies LLC now owns 266,500 shares of the company’s stock valued at $4,704,000 after buying an additional 43,800 shares during the period. Finally, Cubist Systematic Strategies LLC grew its position in Afya by 136.9% during the second quarter. Cubist Systematic Strategies LLC now owns 35,254 shares of the company’s stock worth $622,000 after buying an additional 20,370 shares in the last quarter. 88.02% of the stock is owned by institutional investors and hedge funds.

About Afya

(Get Free Report)

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.

Featured Stories

Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.